Blueprint studio · Spec sheets · Amber callouts · Free shipping over $75

gdicopiadoras.com.br Blueprint · Rev.39

Sheet A · Product board

Unit price

USD22.35

USD47.35

Pay in 4 interest-free payments of $5.59 Learn more

Field rating

4.6

Verified studio score · Spec revision current

Fit · Size

glutathione supplement korea brand

glutathione supplement korea brand Rho Liposomal Volume:10ml javon dihexa clinical trial human

SKU: 36852765249

Dispatch

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 27 - Nov 1

Description

glutathione supplement korea brand Rho Liposomal Volume:10ml javon dihexa clinical trial human

dihexa clinical trial human trials studies Dihexa: Mechanism, Effects & Research First in human Unlocking the Potential of Dihexa – Dihexa: Cognitive Health Peptide Research – Dihexa | PRPEPS | Premier –

Para continuar, ingresa atu cuenta trace-id: 27cfc658-8227-4fe0-ad9d-2da9b8d0cf62 Usamos cookies para mejorar tu experiencia en Mercado Libre

javon

Volume:10ml

L., Heylen, E., De Keersmaecker, K

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

Targeting the HER2-ELF3-KRAS axis: a novel therapeutic strategy for KRASG13D colorectal cancer | Molecular Cancer

Targeting the HER2-ELF3-KRAS axis: a novel therapeutic strategy for KRASG13D colorectal cancer | Molecular Cancer

US$ 25.22

4.6 (25 reviews)

Impact of KRAS mutation on the tumor microenvironment in colorectal cancer

Impact of KRAS mutation on the tumor microenvironment in colorectal cancer

US$ 24.50

4.9 (24 reviews)

Constitutional Activation of KRAS

Constitutional Activation of KRAS

US$ 28.42

4.0 (24 reviews)

JCI

JCI

US$ 24.97

4.5 (23 reviews)

Unveiling the role of KRAS in tumor immune microenvironment

Unveiling the role of KRAS in tumor immune microenvironment

US$ 22.15

4.5 (11 reviews)

The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives

The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives

US$ 23.61

5.0 (26 reviews)

KRAS

KRAS

US$ 23.10

5.0 (8 reviews)

The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy

The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy

US$ 28.49

4.0 (25 reviews)

Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma

Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma

US$ 20.06

4.6 (18 reviews)

KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer

KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer

US$ 26.58

4.7 (17 reviews)

Research advances in the treatment of KRAS mutant colorectal cancer from Prof. Guoquan Gao's group at Zhongshan School of Medicine-中山大学 SUN YAT-SEN UNIVERSITY

Research advances in the treatment of KRAS mutant colorectal cancer from Prof. Guoquan Gao's group at Zhongshan School of Medicine-中山大学 SUN YAT-SEN UNIVERSITY

US$ 25.03

4.3 (25 reviews)

Frontiers

Frontiers

US$ 22.64

4.2 (14 reviews)

KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy

KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy

US$ 24.56

5.0 (27 reviews)

Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex: Cell Reports

Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex: Cell Reports

US$ 21.21

4.7 (18 reviews)

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor

US$ 21.53

5.0 (15 reviews)

KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression

KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression

US$ 21.90

4.2 (5 reviews)

KRAS-targeted therapies in cancer: novel approaches and overcoming resistance

KRAS-targeted therapies in cancer: novel approaches and overcoming resistance

US$ 27.09

4.9 (17 reviews)

Anticancer activity of RAS-GTP inhibition in cholangiocarcinoma: Cancer Cell

Anticancer activity of RAS-GTP inhibition in cholangiocarcinoma: Cancer Cell

US$ 20.03

4.9 (7 reviews)

Kras: structure and activation. (A) The Kras gene. Mutations in human

Kras: structure and activation. (A) The Kras gene. Mutations in human

US$ 24.11

4.3 (14 reviews)

What should we know about the 'undruggable' target KRAS?

What should we know about the 'undruggable' target KRAS?

US$ 21.09

4.4 (11 reviews)